The invention is in the medical field, and is particularly useful in percutaneous procedures such as embolization.
In certain medical procedures, such as blood vessel embolization, it is desired to inject particles into the body. The procedure is a minimally invasive alternative to surgery. The purpose of embolization is to prevent blood flow to an area of the body, which effectively can shrink a fibroid, such as a uterine fibroid. It can also shrink a tumour or block an aneurysm. It is typically done by injecting blocking particles into a blood vessel.
The procedure is carried out as an endovascular procedure by a radiologist in an interventional suite. It is common for most patients to have the treatment carried out with little or no sedation, although this depends largely on the organ to be embolized.
Access to the organ in question is acquired by means of a guidewire and catheter. The position of the correct artery or vein supplying the undesired tissue in question is located by X-Ray images. These images are then used as a map for the radiologist to gain access to the correct vessel by selecting an appropriate catheter and or wire, depending on the shape of the surrounding anatomy
The blocking particles are mixed into a saline solution, sometimes a contrast agent is added (to make the solution opaque to X-Rays). The blocking particles have to be of certain sizes, typically between 0.1 mm to 1 mm, in order to block the blood vessel at the right diameter. Such particles tend to settle very quickly out of the solution as they are heavier than water, causing an uneven concentration of particles during the injection. The settling occurs in as little as a few seconds. It is inconvenient to keep shaking the syringe used for injection, as the whole process is performed in a few seconds and the doctor has to concentrate on injecting the correct amount. It is desired to have a syringe that can keep the particles uniformly dispersed in the saline solution regardless of delays in the injection process or speed of the injection. Since the syringes used are low cost disposable items, it is desired that the device used to keep the particles uniformly dispersed will also be very low cost and disposable. The ideal mixing syringe needs the following attributes:
A. Ability to be re-filled multiple times during a procedure. This rules out any single-use designs, typically using the rupturing of a membrane to allow mixing.
B. Generate a strong mixing action, preferable by creating a vortex in the mixture.
C. Use the minimum modification to a standard syringe.
Prior art mixing syringes, such as disclosed in U.S. Pat. No. 7,883,490 are designed to mix together two materials stored separately in two compartments. They are not designed to stir up a pre-mixed solution. Prior art syringes designed to stir-up embolization mixtures, such as disclosed in US2009/0247985, are needlessly complex. Also, many of the prior art mixing syringes are not designed to be filled with the pre-mixed solution just before use. This is required during embolization, as the correct volume and ratio of saline, particles and contrast agent has to be customized to the procedure by the doctor. The current invention acts as a regular syringe, allowing filling and injecting at any time, but it keeps the solution stirred up during injection. Similar to a regular syringe, it can be re-used several times during a procedure, if more particles have to be injected. The invention can be manufactured out of a regular syringe, which is a very low cost item.
A movable mixing disc is inserted into a regular syringe. The mixing disc has a small hole covered by a fine screen, allowing only saline solution to get behind disc. When the plunger of the syringe is pressed, the saline solution emerges from the mixing disc hole as a high velocity jet, stirring up the settled particles. As the ejection continues, the mixing disc is pushed forward by the plunger in order to eliminate any unused volume.
Referring now to
From the moment seal 3 touches disc 8 the disc is pushed forward towards the tube 4 until the syringe is empty and disc 5a is in position 5a′. The operation can now be repeated, if desired.
It is desirable to make hole 9 at an angle to the axis of the syringe in order to create a vortex 111. An even more effective vortex 111 can be created if hole 9 is molded as a curved arc, both in the plane of the drawing and also in the plane perpendicular to the drawing.
Disc 5a can be molded in one piece, including screen 10. Alternatively, screen 10 can be bonded to molded disc 5a. The fit between disc 5a and bore of syringe 1 is not critical as the particles are relatively large. It was found out that for best results the diameter of disc 5a should be 0.1-0.2 mm smaller than the inside diameter of syringe 1.
While the example given is for embolization, the invention can be used to mix and two components, including two liquids.
The disc 5 can also be made out of pressed sheet metal 11. This is shown as disc 5b in
In order to eliminate the need of molding custom syringes it was found out that the slight ridge 8 can be formed in existing syringes by briefly heating up the area of ridge 8 and pressing the walls in slightly, using a split ring slightly smaller than the outside diameter of the syringe. Other ways of creating a ridge without molding is pressing into the syringe a thin walled ring, held by friction.
If desired the invention can be manufactured out of a standard disposable syringe, without any modifications. The movable disc 5a is attached to the outlet side of the syringe with a short string that only allows it to move a limited distance. The string 13 is bonded by heat to the syringe or uses an anchor 14. This is shown in
In operation tube 4 is first inserted into a mixing bowl where the ingredients are mixed together. The mixture is sucked into the syringe. After filling the syringe is held vertically to help trapped air escape and plunger moved to expel all air. Afterwards tube 4 is moved to the catheter or needle used for the procedure and mixture is injected.
An additional improvement in mixing is to adjust the density of particles 7 to match the density of liquid 6, typically a saline solution with a density around 1. since the materials used to make particles 7 (plastic, glass or ceramic) have a density greater than 1, they have to be made hollow. The technology of manufacturing small hollow spheres, known as micro-balloons, is well known and many polymers as well as glasses are commercially available in micro-balloon form. One supplier is Henkel (http://www.henkelna.com/cps/rde/xchg/henkel_us/hs.xsl/brands-1556.htm?iname=Dualite%25C2%25AE&countryCode=us&BU=industrial&parentredDotUID=0000000GFR&redDotUID=0000000GFR&brand=000000QTQE
Both ideas can be combined: micro-balloon shaped polymer or glass spheres with a density around 1 can be dispensed from a syringe with a mixing disc.
The present application claims the benefit under 35 U.S.C. §119(e) of U.S. Provisional Application No. 61/632,263 filed on Jan. 23, 2012.
Number | Name | Date | Kind |
---|---|---|---|
2514454 | Nicholson | Jul 1950 | A |
3493503 | Mass | Feb 1970 | A |
3548825 | Shaw | Dec 1970 | A |
3570486 | Engelsher et al. | Mar 1971 | A |
3606094 | Mills et al. | Sep 1971 | A |
3661265 | Greenspan | May 1972 | A |
3724077 | Preston et al. | Apr 1973 | A |
3889674 | Cilento | Jun 1975 | A |
4031892 | Hurschman | Jun 1977 | A |
4041945 | Guiney | Aug 1977 | A |
4116240 | Guiney | Sep 1978 | A |
4412836 | Brignola | Nov 1983 | A |
4435507 | Stenkvist | Mar 1984 | A |
4437858 | Ty | Mar 1984 | A |
4698299 | Janoff et al. | Oct 1987 | A |
4751921 | Park | Jun 1988 | A |
4776704 | Kopunek et al. | Oct 1988 | A |
4981468 | Benefiel et al. | Jan 1991 | A |
5002537 | Hoffman et al. | Mar 1991 | A |
5069670 | Vetter et al. | Dec 1991 | A |
5122117 | Haber et al. | Jun 1992 | A |
5139490 | Vetter et al. | Aug 1992 | A |
5244465 | Michel | Sep 1993 | A |
5298023 | Haber et al. | Mar 1994 | A |
5308340 | Harris | May 1994 | A |
5320603 | Vetter et al. | Jun 1994 | A |
5360410 | Wacks | Nov 1994 | A |
5372029 | Brandes | Dec 1994 | A |
5435076 | Hjertman et al. | Jul 1995 | A |
5501673 | Hjertman et al. | Mar 1996 | A |
5514097 | Knauer | May 1996 | A |
5542411 | Rex | Aug 1996 | A |
5549561 | Hjertman et al. | Aug 1996 | A |
5549575 | Giambattista et al. | Aug 1996 | A |
5554134 | Bonnichsen | Sep 1996 | A |
5592866 | Sher | Jan 1997 | A |
5626566 | Petersen et al. | May 1997 | A |
5693027 | Hansen et al. | Dec 1997 | A |
5716338 | Hjertman et al. | Feb 1998 | A |
5725500 | Micheler | Mar 1998 | A |
5725508 | Chanoch et al. | Mar 1998 | A |
5785682 | Grabenkort et al. | Jul 1998 | A |
5785692 | Attermeier et al. | Jul 1998 | A |
5788670 | Reinhard et al. | Aug 1998 | A |
5820602 | Kovelman et al. | Oct 1998 | A |
5823998 | Yamagata | Oct 1998 | A |
5891087 | Ohtani et al. | Apr 1999 | A |
6036675 | Thorne et al. | Mar 2000 | A |
6106501 | Michel | Aug 2000 | A |
6126646 | Hansen et al. | Oct 2000 | A |
6203529 | Gabriel et al. | Mar 2001 | B1 |
6241709 | Bechtold et al. | Jun 2001 | B1 |
6277097 | Mikkelsen et al. | Aug 2001 | B1 |
6319225 | Sugita et al. | Nov 2001 | B1 |
6331173 | Ljungquist | Dec 2001 | B1 |
6419656 | Vetter et al. | Jul 2002 | B1 |
6582404 | Klitgaard et al. | Jun 2003 | B1 |
6582408 | Buch-Rasmussen et al. | Jun 2003 | B1 |
6645179 | Ishikawa et al. | Nov 2003 | B1 |
6679248 | Stadelhofer | Jan 2004 | B2 |
6793646 | Giambattista et al. | Sep 2004 | B1 |
6817987 | Vetter et al. | Nov 2004 | B2 |
6899698 | Sams | May 2005 | B2 |
7081108 | Langley et al. | Jul 2006 | B2 |
7101354 | Thorne, Jr. et al. | Sep 2006 | B2 |
7402150 | Matsumoto et al. | Jul 2008 | B2 |
7686782 | Kirchhofer et al. | Mar 2010 | B2 |
7749200 | Graf et al. | Jul 2010 | B2 |
7771398 | Knight et al. | Aug 2010 | B2 |
7811263 | Burren et al. | Oct 2010 | B2 |
7815598 | Hommann et al. | Oct 2010 | B2 |
RE41956 | Klitgaard et al. | Nov 2010 | E |
7828172 | Stradella et al. | Nov 2010 | B2 |
7850662 | Veasey et al. | Dec 2010 | B2 |
7867202 | Moser et al. | Jan 2011 | B2 |
7883490 | Casey, II et al. | Feb 2011 | B2 |
7918832 | Veasey et al. | Apr 2011 | B2 |
7918833 | Veasey | Apr 2011 | B2 |
7967779 | Bertron et al. | Jun 2011 | B2 |
8002734 | Bassarab et al. | Aug 2011 | B2 |
8075515 | Matusch | Dec 2011 | B2 |
8092421 | Seiferlein et al. | Jan 2012 | B2 |
8092422 | Seiferlein et al. | Jan 2012 | B2 |
8096971 | Bassarab et al. | Jan 2012 | B2 |
8152766 | Karlsson et al. | Apr 2012 | B2 |
8187233 | Harms et al. | May 2012 | B2 |
8246577 | Schrul et al. | Aug 2012 | B2 |
8267900 | Harms et al. | Sep 2012 | B2 |
8298175 | Hirschel et al. | Oct 2012 | B2 |
8366680 | Raab | Feb 2013 | B2 |
8376993 | Cox et al. | Feb 2013 | B2 |
8398593 | Eich et al. | Mar 2013 | B2 |
8414541 | Spofforth | Apr 2013 | B2 |
8439864 | Galbraith et al. | May 2013 | B2 |
20010053894 | Steenfeldt-Jensen et al. | Dec 2001 | A1 |
20020033367 | Prince et al. | Mar 2002 | A1 |
20020165500 | Bechtold et al. | Nov 2002 | A1 |
20020173752 | Polzin | Nov 2002 | A1 |
20030032935 | Damiano et al. | Feb 2003 | A1 |
20040092883 | Casey et al. | May 2004 | A1 |
20040108339 | Hansen et al. | Jun 2004 | A1 |
20040158226 | Soo Hoo et al. | Aug 2004 | A1 |
20040186441 | Graf et al. | Sep 2004 | A1 |
20050049550 | Kirchhofer et al. | Mar 2005 | A1 |
20050154352 | Gurtner et al. | Jul 2005 | A1 |
20050177114 | Michel et al. | Aug 2005 | A1 |
20050261634 | Karlsson | Nov 2005 | A1 |
20060111666 | Hommann et al. | May 2006 | A1 |
20060178638 | Reynolds | Aug 2006 | A1 |
20060178644 | Reynolds | Aug 2006 | A1 |
20060254788 | Bucher | Nov 2006 | A1 |
20060258988 | Keitel et al. | Nov 2006 | A1 |
20070027430 | Hommann | Feb 2007 | A1 |
20070060875 | Bassarab et al. | Mar 2007 | A1 |
20070060877 | Bassarab et al. | Mar 2007 | A1 |
20070129673 | Bassarab et al. | Jun 2007 | A1 |
20070163366 | Jeong et al. | Jul 2007 | A1 |
20070197975 | Burren et al. | Aug 2007 | A1 |
20070270739 | Kirchhofer et al. | Nov 2007 | A1 |
20080071226 | Moser et al. | Mar 2008 | A1 |
20080126102 | Shirakawa et al. | May 2008 | A1 |
20080300550 | Schiller et al. | Dec 2008 | A1 |
20090137964 | Enggaard et al. | May 2009 | A1 |
20090157041 | Pettis et al. | Jun 2009 | A1 |
20090209920 | Moller et al. | Aug 2009 | A1 |
20090247985 | Melsheimer et al. | Oct 2009 | A1 |
20090254027 | Moller | Oct 2009 | A1 |
20100030551 | Ark et al. | Feb 2010 | A1 |
20100036320 | Cox et al. | Feb 2010 | A1 |
20100069845 | Marshall et al. | Mar 2010 | A1 |
20100082013 | Braga et al. | Apr 2010 | A1 |
20100087799 | Galbraith et al. | Apr 2010 | A1 |
20100185156 | Kanner et al. | Jul 2010 | A1 |
20100262074 | Seiferlein et al. | Oct 2010 | A1 |
20100274198 | Bechtold | Oct 2010 | A1 |
20100323322 | Jessop et al. | Dec 2010 | A1 |
20100327007 | Fransson et al. | Dec 2010 | A1 |
20110060274 | Kuhn | Mar 2011 | A1 |
20110100921 | Heinrich | May 2011 | A1 |
20110152784 | Veasey et al. | Jun 2011 | A1 |
20110152822 | Drunk et al. | Jun 2011 | A1 |
20110196310 | Cronenberg | Aug 2011 | A1 |
20110201999 | Cronenberg et al. | Aug 2011 | A1 |
20110224622 | Karlsson | Sep 2011 | A1 |
20110230827 | Mori et al. | Sep 2011 | A1 |
20120041366 | Fayyaz et al. | Feb 2012 | A1 |
20120046613 | Plumptre | Feb 2012 | A1 |
20120078171 | Seiferlein et al. | Mar 2012 | A1 |
20120078195 | Harms et al. | Mar 2012 | A1 |
20120089100 | Veasey et al. | Apr 2012 | A1 |
20120095413 | Nzike et al. | Apr 2012 | A1 |
20120118139 | Seiferlein et al. | May 2012 | A1 |
20120130316 | Boyd et al. | May 2012 | A1 |
20120136298 | Bendix et al. | May 2012 | A1 |
20120136306 | Bartha | May 2012 | A1 |
20120136315 | Wieselblad et al. | May 2012 | A1 |
20120172816 | Boyd et al. | Jul 2012 | A1 |
20120209171 | Vedrine et al. | Aug 2012 | A1 |
20120283646 | Kouyoumjian et al. | Nov 2012 | A1 |
20120289929 | Boyd et al. | Nov 2012 | A1 |
20120310168 | Plumptre et al. | Dec 2012 | A1 |
20130018327 | Dasbach et al. | Jan 2013 | A1 |
20130046245 | Raab et al. | Feb 2013 | A1 |
20130053789 | Harms et al. | Feb 2013 | A1 |
20130096513 | Smith | Apr 2013 | A1 |
20130131605 | Hiles | May 2013 | A1 |
20130190719 | Smith et al. | Jul 2013 | A1 |
20130211326 | Dashbach et al. | Aug 2013 | A1 |
20130218098 | Chung | Aug 2013 | A1 |
20130245562 | Kouyoumjian et al. | Sep 2013 | A1 |
20130253433 | Senior et al. | Sep 2013 | A1 |
Number | Date | Country |
---|---|---|
10356335 | Jun 2005 | DE |
102004055298 | May 2006 | DE |
0513128 | Nov 1992 | EP |
0829268 | Mar 1998 | EP |
1923085 | May 2008 | EP |
1974761 | Oct 2008 | EP |
2263721 | Dec 2010 | EP |
2263722 | Dec 2010 | EP |
2514454 | Oct 2012 | EP |
2847887 | Jun 2004 | FR |
1020110041826 | Apr 2011 | KR |
WO 9204926 | Apr 1992 | WO |
WO 2006079898 | Aug 2006 | WO |
WO 2009141005 | Nov 2009 | WO |
WO 2010003262 | Jan 2010 | WO |
WO 2010105376 | Sep 2010 | WO |
WO 2011131775 | Oct 2011 | WO |
WO 2011131779 | Oct 2011 | WO |
WO 2011154488 | Dec 2011 | WO |
WO 2012010832 | Jan 2012 | WO |
WO 2012072568 | Jun 2012 | WO |
WO 2012085017 | Jun 2012 | WO |
WO 2012128699 | Sep 2012 | WO |
WO 2012152666 | Nov 2012 | WO |
WO 2013033227 | Mar 2013 | WO |
WO 2013043861 | Mar 2013 | WO |
Entry |
---|
International Search Report and Written Opinion dated May 15, 2013 for PCT/US2013/022561. |
Number | Date | Country | |
---|---|---|---|
20130226148 A1 | Aug 2013 | US |
Number | Date | Country | |
---|---|---|---|
61632263 | Jan 2012 | US |